Class of Stock [Axis] Series A Preferred Stock [Member] Counterparty Name [Axis] Officers Directors And Contractors [Member] Related Party Transaction [Axis] Related Party Interest [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Common Stock Issuable [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Deferred Revenue Arrangement Type [Axis] Customer Advances [Member] Deferred Shipments [Member] Transaction Type [Axis] Commissions Payable [Member] Antidilutive Securities [Axis] Options And Warrants [Member] Product and Service [Axis] Medical Testing [Member] Wellness Devices [Member] Nutritional [Member] Other Returns [Member] Customer [Axis] Medical And Academic [Member] Customers And Direct Sales [Member] Reseller [Member] Two Consultants [Member] Contractors And Professional [Member] Directors And An Officer [Member] Board Members And Officers [Member] Two Note Holders [Member] Award Type [Axis] Stock Option And Warrants [Member] Warrant [Member] Long-Term Debt, Type [Axis] Howard Notes [Member] Goff Note [Member] Insurance Notes [Member] Alder Notes Net Of Discount [Member] EIDL Notes [Member] Stripe Capital [Member] Other Notes [Member] Howard Note [Member] Genisis Glass Note [Member] Doc Sun Biomedical Holdings Inc [Member] Debt Instrument [Axis] EIDL Loan [Member] SBA Loan 1 [Member] SBA Loan 2 [Member] Related Party Debts [Member] Related and Nonrelated Parties [Axis] Libertas Trust [Member] Wilshire Holding Trust [Member] Resco Enterprises Trust [Member] Avis Trust [Member] Joesph Bird [Member] Thomas Power [Member] Richard Long [Member] Jody Walker [Member] Resides Enterprises [Member] Gary Hennerberg [Member] Prior Officers And Board Members [Member] Bioregenx [Member] Nu Life Sciences [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] ASSETS Current Assets: Cash and cash equivalents Accounts receivable Inventories, net Prepaid expenses and other current assets Total current assets Property and equipment, net TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable Accounts payable - related parties Accrued expenses Accrued interest - related party Notes payable and loans (including $522,500 in default) Notes payable and loans - related parties Deferred revenue Total current liabilities Royalty Liability Notes payable and loans, net of current TOTAL LIABILITIES Stockholders’ Deficit: Common stock, $0.001 par value; 1,500,000,000 shares authorized; 971,575,183 issued and outstanding as of March 31, 2026 and 969,017,081 as of December 31, 2025 Series A preferred stock, non-dividend, 2,500 votes per share, $0.001 par value, 50,000,000 authorized; issued and outstanding 3,800 shares Additional paid-in capital Accumulated deficit TOTAL STOCKHOLDERS' DEFICIT TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT Debt in default Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Income Statement [Abstract] Revenues: Net sales Cost of sales Gross profit Operating expenses: Distributors incentives Selling, general and administrative (including equity compensation granted to officers, directors and contractors of $30,353 in the period ended March 31, 2026 and $75,633 in the period ended March 31, 2025) Total operating expenses Loss from operations Other Income/(Expense): Write-off of accrued liabilities Other income Interest expense and financing costs (Including related party interest of $38,088 in the three months ended in March 31, 2026 and $35,455 in March 31, 2025. Other income and expense (net) Net loss Weighted average common shares outstanding - basic Weighted average common shares outstanding - diluted Loss per share - basic Loss per share - diluted Comprehensive Loss: Net Loss Other comprehensive loss Foreign currency translation adjustment Other comprehensive loss Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Share based compensation Interest expense Beginning balance, value Beginning balance, shares Issuance of common shares for services Issuance of common shares for services, shares Issuance and vesting of common shares for services Issuance and vesting of common shares for services, shares Issuance of common shares to directors Issuance of common shares to directors, shares Issuance of common shares as loan incentive Issuance of common shares as loan incentive, shares Issuance of common shares for settlement of payables Issuance of common shares for settlement of payables, shares Net loss Other Comprehensive loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Amortization of debt discounts Fair value of common shares issued to officers and directors for services Fair value of common shares issued for services Fair value of common shares issued as loan incentives Interest capitalized to debt balance Write-off of accrued liabilities Change in operating assets and liabilities: Accounts receivable Inventories Prepaid expenses and other assets Accounts payable Accounts payable - related parties Accrued expenses and other liabilities Accrued interest - related parties Deferred Revenue Net cash provided by operating activities FINANCING ACTIVITIES: Note and loan payments Increase in note and loan balances Net cash used in financing activities NET EFFECT OF EXCHANGE RATE FLUCTUATIONS NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, BEGINNING BALANCE CASH AND CASH EQUIVALENTS, ENDING BALANCE CASH PAID FOR: Interest Income taxes NON-CASH INVESTING AND FINANCING ACTIVITIES: Issuance of common stock to settle accounts payable Net non-cash activities Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Inventory Disclosure [Abstract] INVENTORIES Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] PREPAID EXPENSES AND OTHER CURRENT ASSETS Equity [Abstract] ISSUANCE OF COMMON STOCK AND OPTIONS Debt Disclosure [Abstract] LOANS Related Party Transactions [Abstract] RELATED-PARTY TRANSACTIONS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Segment Reporting [Abstract] SEGMENT INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Organization and Business Basis of Presentation of Unaudited Financial Information Going Concern Use of Estimates Fair value of financial instruments Accounts Receivable Revenue Recognition Other Revenue Disaggregation of Revenue Deferred Revenue Independent Business Partners Incentives Equity-Based Compensation Net Income (Loss) per Share Segments Recently Issued Accounting Standards Schedule of disaggregation of revenue Schedule of inventories Schedule of prepaid expenses and other current assets Schedule of stock options and warrants outstanding Schedule of options and warrants outstanding and exercisable Schedule of loans from unrelated parties Schedule of related party debt Schedule of secured related party loans Schedule of segment reporting Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Total Net Sales Qualitative and Quantitative Information, Transferor's Continuing Involvement [Table] Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items] Net loss Cash in operations Stockholders' deficit Cash on hand Notes payable in default amount Deferred revenue Equity instruments issued as refunds Commissions payable Adjusted reserve Accrued liability for warranty reserve Dilutive shares Reportable segment Total Finished Goods Prepaid commissions Other current assets Total Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of shares, beginning balance Weighted average exercise price, beginning balance Number of shares, granted Weighted average exercise price, granted Number of shares, exercised Weighted average exercise price, exercised Number of shares, forfeited Weighted average exercise price, forfeited Number of shares, ending balance Weighted average exercise price, ending balance Number of shares, exercisable Weighted average exercise price, exercisable Range of exercise price, lower range Range of exercise price, upper range Options and warrants exercisable Weighted average exercise price Weighted average remaining (years) Stock, Class of Stock [Table] Class of Stock [Line Items] Stock issued for services, shares Stock granted for services, value Share based compensation Stock issued for services, value Stock issued new, shares Stock issued new, value Stock converted, shares converted Shares converted, value Warrants outstanding Warrants exercisable Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Loans from unrelated parties Less current portion Total long term Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] Note payable - related party Unsecured notes Note issued Shares issued Fair value Loan discount Debt face amount Equity or debt financing Financing interest rate Payments of principal and interest per month Conversions price Number of shares issued Debt stated interest rate Principal payments Debt outstanding Long-term balance Defaulted loan Current liabilities Proceeds from loan Interest expense Loan rate Principal payments Loans payable Balance principal Accrued interest Related Party Transaction [Table] Related Party Transaction [Line Items] Related party loan Rent paid Royalty expense Notes balance Legal fees Proceeds from related party Net Sales Cost of goods sold Salaries and wages Stock-based compensation Legal and accounting Depreciation and amortization Other operating expenses Interest expense Other income Number of reportable segment Number of operating segment Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Nonoperating Nonoperating Income (Expense) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Other Accounts Payable Increase (Decrease) in Accounts Payable, Related Parties Repayments of Notes Payable Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name RevenueRecognitionDeferredRevenuePolicyTextBlock Deferred Revenue [Default Label] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Loans Payable, Current Debt Instrument, Periodic Payment, Principal Other Depreciation and Amortization Interest Expense, Operating and Nonoperating Other Income